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Abstract 
Toxoplasma gondii, an obligate intracellular apicomplexan parasite, utilizes gliding 
motility for active penetration and proactive egress from host cells. Gliding motility is made 
possible in apicomplexan parasites by use of the myosin motor complex, which is an actin-
activated molecular motor. Toxoplasma actin is encoded by the single copy ACT1 gene which is 
transcribed and translated into a single actin isoform and is inherently unstable in the filamentous 
form. In T. gondii, globular actin polymerizes to filamentous actin and is then driven rearward by 
the myosin motor during gliding motility. Prior research has shown differences between 
Apicomplexan and mammalian actin and myosin. The in vitro motility assay is used to study the 
Toxoplasma myosin motor complex, and chicken skeletal muscle actin is used in place of 
Toxoplasma actin. Here, recombinant Toxoplasma actin is expressed, purified, and polymerized 
in preparation for labeling and use in the in vitro motility assay. Confirmation of Toxoplasma 
actin expression was achieved by sequencing baculovirus encoding recombinant Toxoplasma 
actin and western blot analysis. Purification was achieved via nickel affinity chromatography, 
followed by cycles of polymerization and depolymerization. Preparing stabilized and labeled 
actin filaments allows for the comparison of the speeds Toxoplasma myosin moves Toxoplasma 
actin versus mammalian actin.    
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Author Summary 
The Apicomplexa phylum, which includes Toxoplasma gondii, is responsible for a 
number of diseases (including toxoplasmosis, malaria, and cryptosporidiosis) and deaths 
worldwide. T. gondii requires the ability to invade and exit cells of the host to remain infectious 
as well as to replicate. This is all achieved by parasite motility – dependent on a complex of 
proteins, including actin and myosin, which are relatively well conserved within the 
Apicomplexa phylum. However, Apicomplexan actins differ in a number of key respects from 
mammalian actins. The motility assay utilized to study the parasite motor complex currently uses 
chicken skeletal muscle actin in place of Toxoplasma actin. We work here to express, purify, and 
stabilize Toxoplasma actin for use in the motility assay currently used to study the T. gondii 
motility complex, to enable a preliminary comparison of the interaction of chicken skeletal 
muscle actin versus Toxoplasma actin with recombinant Toxoplasma myosin motor complex. 
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Introduction 
Toxoplasma gondii is capable of infecting nucleated cells of warm-blooded vertebrates, 
causing toxoplasmosis. Infections are typically caused by ingestion of contaminated food or 
water (1). T. gondii, an obligate intracellular apicomplexan parasite, utilizes gliding motility for 
active penetration and proactive egress from host tissues and cells (2-4). The study of 
Apicomplexan motility is important because motility is required to cause morbidity and mortality 
in hosts. Gliding motility is made possible in apicomplexan parasites by use of the myosin motor 
complex (Figure 1), which is an actin-activated molecular motor, situated within the cortical 
domain of the parasite. Rearward translocation of actin-associated cell surface adhesins is driven 
by the myosin motor complex anchored to an internal membrane complex, causing forward 
movement of the parasite (5, 6). 
Apicomplexan myosin is composed of three domains: the force generating and actin-
binding motor domain, the neck domain, and the C-terminal tail domain, which coordinates the 
light chains utilized in parasite motility (7). Myosin utilizes chemical energy from ATP 
hydrolysis to create mechanical energy. Motility in T. gondii involves Myosin A (TgMyoA), 
which is associated with two light chains, Myosin Light Chain 1 (TgMLC1) and Essential Light 
Chain 1 (TgELC1). When both TgMLC1 and TgELC1 are bound to the TgMyoA motor, the 
speed of actin movement is close to that of the motor complex isolated from parasites (8). To 
express a functional TgMyoA motor, a T. gondii myosin co-chaperone is required for proper 
folding of the TgMyoA heavy chain. This finding allowed for high yield expression of the 
TgMyoA motor complex and has allowed further detailed study of the Toxoplasma motor 
complex (8). It has also been shown that the TgMyoA heavy chain is one of 11 myosin heavy 
chains found in T. gondii and is a part of the TgMyoA motor located between the inner 
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membrane complex and plasma membrane in parasites (9). TgMyoA is distinguished from other 
myosin motors due to the presence of Gln, rather than an acidic residue or a phosphorylatable 
residue in a key actin binding surface loop that is otherwise highly conserved (10, 11).  
Toxoplasma actin is encoded by the single copy ACT1 gene which is transcribed and 
translated into a single actin isoform (5, 12). Toxoplasma actin, not host cell actin, has been 
shown to be essential for survival with gliding motility and host cell invasion both being 
compromised by lack of actin. Parasite egress is also not observed in the absence of parasite 
actin (4, 13, 14). Parasite actin is found primarily in the globular form (G-actin), and when 
filaments polymerize for motility, they are short and intrinsically unstable (15, 16). Filamentous 
actin (F-actin) consists of a right-handed helical spiral of two interwoven parallel strands formed 
by a self-polymerized head-to-tail dimer (17). The failure to generate cross-strand interactions 
that provide strong annealing may lead to the inherent instability of T. gondii ACT1 (TgACT1) 
(18). The abundance of F-actin has been shown to be rate limiting for motility, as the 
polymerization of actin filaments coordinates the initiation and directionality of movement (19).  
In most eukaryotic cells, the sequence of actin is highly conserved, however 
apicomplexans encode more divergent actins. TgACT1 shows an 83% amino acid identity with 
mammalian muscle actin, and a 93.1% identity with Plasmodium falciparum actin (Figure 2a) 
(12, 15). Some amino acid differences can be seen at residues found to interact with the actin 
binding domain of myosin (Figure 2b, green boxes) (20). Additional amino acids interacting with 
the binding domain of myosin have also been identified (Figure 2b, orange boxes) (21). 
Apicomplexan parasite actins share divergent sequence features at the monomer surface with 
actins of close relatives, such as ciliates. These features have the potential to affect protein-
protein interactions with actin-binding proteins or within the filaments. One such difference in T. 
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gondii is Arg277 (Figure 2b, red box), which is implicated in intermonomer salt bridge and 
hydrogen bond interactions. In TgACT1, this salt bridge is likely weakened due to an 
unfavorable Arg-Arg pairing (18). Another alteration in apicomplexan actins is seen within the 
hydrophobic plug. In T. gondii, according to the Holmes model, there would likely be additional 
destabilization between subunits across the filaments due to the alteration in the hydrophobic 
plug (Figure 2b, pink boxes). Experiments in which Gly200 and Lys270 in Toxoplasma actin 
have been substituted to the mammalian actin residue have shown Toxoplasma actin filaments 
that formed significantly longer filaments than the wild type Toxoplasma actin filaments (15, 
18). The actin-binding proteins found within apicomplexans include actin depolymerizing factor, 
cyclase associated protein, profilin, and capping protein (22, 23).   
Recombinant Toxoplasma actin (rTgACT1), produced in the baculovirus expression 
system, can be stabilized by the addition of equimolar levels of phalloidin to form long stable 
filaments that resemble conventional actin (15). Mapping of the phalloidin-binding domain in 
Plasmodium falciparum and T. gondii has shown six specific differences in residues contacting 
phalloidin in TgACT1 and PfACTII (actin in P.  falciparum) versus mammalian muscle actin. 
These differences may cause the decreased binding efficiency of phalloidin to parasite actin 
filaments (15). Stabilization of Toxoplasma actin can also be achieved by the reversion of two 
key residues in Toxoplasma actin to match those of mammalian muscle actin (15). When 
expressed in parasites, these substitutions in TgACT1 modestly affected parasite cell division 
over the first 24-36 hours, and detrimentally affected gliding motility, which is supportive of 
conclusions drawn from Jasplakinolide (JAS) stabilization of actin (see below). Parasites 
expressing the stabilized actin moved more slowly, in circles with larger radii, and stalled while 
engaging in gliding motility (15). 
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JAS, a cyclopeptide, is useful for examining actin dynamics in live cells, as it is a 
membrane-permeable probe. JAS induces actin polymerization by binding to and stabilizing 
filaments, releasing monomeric actin from sequestering proteins, and decreasing the critical 
number of subunits necessary to induce polymerization (24, 25). When recombinant TgACT1 
was treated with JAS for artificial stabilization, well defined TgACT1 filaments, with typical 
striations and slight helical twists, were formed in vitro. This led to cross linking between 
filaments, and an increase in overall length of filaments in vitro. However, JAS-treated TgACT1 
filaments were still shorter than rabbit actin filaments (18). In parasites, JAS-treatment induced 
actin filament polymerization at specific sites rather than randomly, and increased TgACT1 
lengths of filaments (18, 26). In addition, video microscopy of JAS-treated parasites showed they 
moved faster but with frequent direction reversals disrupting directed gliding (19).  
The Toxoplasma motor complex has been assayed in in vitro motility assays to study 
TgMyoA function and demonstrated that actin moved at speeds similar to speeds of parasite 
motility on two dimensional surfaces and in three dimensional Matrigel (2, 27). The actin used in 
these in vitro motility assays however was rhodamine-phalloidin labeled chicken skeletal muscle 
actin, not actin from the parasite (8). A recent study demonstrated that P. falciparum MyoA 
moved Plasmodium actin filaments stabilized with JAS at the same speed as skeletal muscle 
actin (28).  
As outlined above, prior research on the apicomplexan gliding motility motor complex 
has shown differences in actin, specifically TgACT1 is considerably divergent from mammalian 
actins which are typically highly conserved.  Prior research has also demonstrated that human F-
actin from skeletal and cardiac muscle, which differ at only four side chains, show differences in 
motility velocity with porcine β-myosin (29). It is unknown whether the Toxoplasma motor 
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complex will interact with and move Toxoplasma actin differently from chicken skeletal muscle 
actin in in vitro motility assays. While one study (28) has done some initial research with the 
Plasmodium motor complex and its ability to translocate Plasmodium versus skeletal muscle 
actin, further research is necessary.  
With prior research demonstrating that there is the possibility for differences in motility 
and the way different F-actins interact with a given myosin, alongside the differences of 
Toxoplasma actin and myosin compared to mammalian actins and myosins, further study of 
TgMyoA function with the actin T. gondii  utilizes for active penetration, proactive egress, and 
motility is necessary to determine whether there is a functional difference between Toxoplasma 
and chicken skeletal muscle actin in motility assays. In this study, we work to purify Toxoplasma 
actin from recombinant baculovirus encoding Toxoplasma actin, that has been polymerized and 
depolymerized, for use in the in vitro motility assay.  
  
Functional Comparison of Toxoplasma and Chicken Skeletal Muscle Actin  9 
 
  
Figure 1. Schematic of T. gondii myosin motor complex. Previously published schematic of T. gondii 
myosin motor complex components (8). In the myosin motor complex, myosin associated with the inner 
membrane complex binds to actin associated with the parasite plasma membrane, and the actin is driven 
rearward. This rearward actin movement drive the parasite forward.  
       
Figure 2a.      Figure 2b. 
Figure 2. Actin Sequence Alignments. (a) Comparative amino acid identity percentage graphed based on 
(b) sequence alignment of Chicken skeletal muscle actin, Toxoplasma actin, and Plasmodium actin. 
Aligned using Clustal Omega multiple sequence aligner (30). Amino acids affecting actin filament stability 
highlighted in red (18) and purple (15). Amino acids interacting with the myosin actin binding domain 
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Results 
Successful expression of recombinant Toxoplasma actin in insect cells (Figure 3a), as 
well as confirming the baculovirus-encoded actin was both free of mutations (Figure 3b) and 
inserted in the vector as described (Figure 3c) (18), demonstrated the recombinant baculovirus 
and Sf9 insect cell system was an effective model for the expression of recombinant Toxoplasma 
actin. 
Purification of Toxoplasma actin was achieved via nickel charged affinity 
chromatography (Figure 4a). Identification of the purified band as actin was confirmed by 
western blotting with an anti-actin antibody (Figure 4b). The His6 tag was removed with 
thrombin to avoid any possible secondary effects on polymerization, depolymerization or any 
motility assay proteins. The slight decrease in molecular weight (to ~42kD) after His6 removal is 
evident on the western blot (Figure 4b). To ensure that actin being fluorescently labeled for use 
in the in vitro motility assay was functional, the purified protein was taken through one cycle of 
polymerization/depolymerization (Figure 4c). From each 200 mL infection, approximately 2.9 
mg of actin were recovered following nickel affinity purification, as determined by comparison 
of the actin band intensity to that of known amounts of low molecular weight standards on an 
Aqua Stained SDS gel (data not shown). With each step following affinity chromatography, 25-
75% of the actin was lost.   
TRITC-phalloidin binds to polymerized actin at the cleft between two monomers (31). 
Polymerized Toxoplasma actin bound by phalloidin was visualized (Figure 5a), however long 
filaments such as those formed by vertebrate actin were not formed (Figure 5b). Potential 
reasons for this are presented in the Discussion. 
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Figure 3a.  
 
Figure 3b.  
 
Figure 3c. 
Figure 3. Verification of TgACT1 expression in Baculovirus system. (a) TgACT1 expression 
by Sf9 cells infected with baculovirus encoding recombinant TgACT1 was verified via 10% SDS-
PAGE and western blot of insect cell extracts probed with rabbit anti-actin primary antibody. 
Different dilutions of the solubilized insect cell pellet (sonicated for either 30- or 60-minutes) were 
loaded, as indicated. RH strain parasites were loaded to provide an actin positive control (box). (b) 
Primer location and sequencing of recombinant TgACT1 in the baculovirus vector. Reference 
sequence (black bar) was constructed electronically via insertion of RH strain T. gondii cDNA 
sequence into pAcHLT-C vector backbone using NdeI and EcorI restriction enzymes. Purple text 
above reference sequence highlights primers used for sequencing. Green arrows indicate primers 
used, direction, and length of sequencing results. (c) Vector map of recombinant pAcHLT-C 
TgACT1 from the Sibley Lab (18), electronically constructed via insertion of RH strain T. gondii 
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Figure 4b.      Figure 4c. 
Figure 4. Purification and labeling of TgACT1. (a) His6-TgACT1 (arrowhead) purified via 
nickel charged affinity resin was resolved on a 10% SDS-PAGE gel and visualized via Aqua Stain 
Protein Gel Stain. (b)Verification of TgACT1 presence after cleavage of His6 from purified 
TgACT1. Samples were resolved via 10% SDS-PAGE and western blot probed with rabbit anti-
actin primary antibody. (c) TgACT1 (arrow) was incubated with F-Actin Buffer salts 
(polymerization conditions) and then dialyzed against G-Actin Buffer (depolymerization 
conditions) and separated after each treatment into pellet (p) and supernatant (s) fractions by 
centrifugation at 300000xg. Samples resolved on a 10% SDS-PAGE gel and visualized via Aqua 
Stain Protein Gel Stain. Additional band (star) is an unknown contaminating protein that appears 
after thrombin cleavage.  
 
      
Figure 5a.    Figure 5b. 
Figure 5. Visualization of polymerized actin. (a) TgACT1 stabilization and labeling was attempted with 
TRITC phalloidin; the phalloidin-treated samples were imaged by fluorescence imaging on a Nikon 
inverted epifluorescence microscope using NIS elements software. (b) Filamentous chicken skeletal muscle 
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Discussion 
Actin is a well-known protein with an important role in the motility of Toxoplasma 
gondii and other apicomplexan parasites. In addition, actin is utilized in motility assays studying 
many other aspects of the actin-myosin motor (8). We show here that it is possible to express 
stabilized recombinant Toxoplasma actin that has been through a cycle of polymerization and 
depolymerization.  
The baculovirus expression vector system is widely utilized for recombinant protein 
production in insect cells due to the large quantities of protein it is able to produce (32). 
Expression of recombinant Toxoplasma actin still required several troubleshooting steps. First, it 
was necessary to ensure that the baculovirus expression system was producing recombinant actin 
and that no mutations were present in the actin sequence. This was accomplished by western blot 
and sequence analysis of TgACT1. Second, due to the viscosity of the insect cell pellet after 
infection with recombinant baculovirus and solubilization in sample buffer, the sample was 
unable to be run on the protein gel. To run the protein on the protein gel, and conduct western 
blot analysis, the cell pellet was water bath sonicated, and heavily diluted, producing clear results 
that confirmed the presence of Toxoplasma actin.  
Successful purification of TgACT1 required additional troubleshooting. Previously 
published methods (15) to express and purify Toxoplasma actin merged with the manufacturer’s 
protocol did not yield purified Toxoplasma actin. Rather it yielded a product with high amounts 
of contaminating protein that eluted earlier than expected off the column. To troubleshoot the 
purification wash and elution buffer volume, the protein was washed in greater volumes of wash 
buffers. However, it was determined that lower amount of imidazole in the wash buffers were 
necessary to remove contaminating proteins from the nickel affinity resin. An imidazole elution 
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gradient was conducted to determine the concentration at which, subjectively, the largest amount 
of contaminating protein was washed off the column, while losing the least amount of actin. 
Using data from these troubleshooting steps, Toxoplasma actin was purified from the nickel 
affinity column.  
Polymerization kinetics and ion requirements of Toxoplasma actin and Plasmodium actin 
have been published previously; however, the findings vary between studies. It has been reported 
that the critical concentration of Toxoplasma actin, the concentration at which actin 
polymerization begins, was ~0.04µM (18). A later publication from the same group (33) reports, 
that upon reexamination, Toxoplasma actin polymerization is isodesmic, and therefore does not 
have a critical concentration. The previous findings are briefly addressed by stating the 
isodesmic conclusion is based off a larger range of actin polymerization concentrations while the 
previous publication only reported at low actin concentrations. Contrasting both results is a 
publication (34) which reports that the critical concentration of Plasmodium actin is ~4µM. 
These three reports describing the kinetics of apicomplexan actin filament formation highlight 
one of the difficulties in studying Toxoplasma actin, that there is no consensus on the dynamics 
of polymerization. In addition, the intrinsic instability of Toxoplasma actin has led to varied g 
forces used to sediment polymerized actin, with different groups achieving success at different g 
forces. Through many rounds of centrifuge speed trouble shooting, we were able to sediment 
polymerized actin (at 300000xg) and depolymerize previously sedimented actin, with the 
depolymerized actin remaining in the supernatant. The need to polymerize and depolymerize 
actin, prior to a final polymerization and stabilization step is supported by the intrinsic instability 
of Toxoplasma actin. Actin is a dynamic protein in the parasite, with actin remaining in 
filamentous form for extremely brief periods of time. Therefore, to best mimic parasite 
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conditions in the in vitro motility assay, the actin used needs to undergo similar dynamics prior 
to use in experimentation. 
When stabilization and labeling of the polymerized actin was attempted with TRITC 
phalloidin, formation and/or stabilization of filaments did not occur. Previous research has 
shown at low actin concentrations, where phalloidin stabilization did not occur, Toxoplasma 
actin that had polymerized formed small clumps rather than filaments (33). The lack of 
stabilization into filaments may have been due to the length of time during which stabilization 
was attempted, or the concentration of phalloidin utilized. Further troubleshooting of 
polymerized Toxoplasma actin stabilization will be necessary prior to use in in vitro motility.  
The in vitro motility assay is utilized frequently to study myosin function, small molecule 
inhibitors of myosin, and additional proteins associated with the myosin motor complex. 
Understanding whether the in vitro motility assay is capturing what is occurring in the parasite is 
important. In in vitro motility assays, if Toxoplasma myosin is shown to move Toxoplasma actin 
as the same speed as chicken skeletal muscle actin, the continued use of chicken skeletal muscle 
actin can be supported. However, if Toxoplasma actin moves at different speeds, it will be 
necessary to repeat previous experiments that have utilized the in vitro motility assay to elucidate 
whether differences in TgMyoAs interaction with Toxoplasma actin affect previously drawn 
conclusions. Additionally, utilization of the ATPase activity assay, to determine if the rate of 
ATP hydrolysis by Toxoplasma myosin varies in the presence of the different actins will further 
demonstrate if the continued use of chicken skeletal muscle actin can be supported when 
studying T. gondii’s motor complex. The continued research of the myosin motor complex as a 
target for pharmacological agents, as well as its importance for parasite motility justify the 
continued research of the associated proteins in the motor complex.  
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Materials and Methods 
Cell Culture 
Sf9 insect cells (Gibco Cell Culture, Gaithersburg, MD) were maintained in Serum Free Medium 
Complete (Gibco Cell Culture) containing 5% (v/v) heat inactivated fetal bovine serum (FBS), 
1% (v/v) Penicillin/Streptomycin (10000U/mL / 10000ug/mL), and 0.05% (v/v) 50mg/mL 
Gentamicin Reagent Solution (Gibco Cell Culture) at 27oC. 
Protein Staining and Western Blotting 
Protein samples were boiled in SDS-PAGE sample buffer at 1X final concentration in the 
presence of β-mercaptoethanol for five minutes. Protein samples were resolved on a 10% SDS-
PAGE gel and visualized by staining with Aqua Stain Protein Gel Stain (Bulldog Bio, 
Portsmouth, NH) or transferred to PVDF for western blot analysis. For western blots, membranes 
were blocked overnight at 4oC with Odyssey Blocking Buffer (LI-COR, Lincoln, NE) diluted 1:1 
with TBS overnight at 4oC. Membranes were incubated for one hour with rabbit anti-actin 
primary antibody (Sibley Lab, St. Louis, MO) diluted 1:1000. Membranes were then washed 
three times for 15 minutes with TBST (0.15M NaCl, 0.02M Tris, pH 7.4, 1% v/v Tween-20) and 
incubated for one hour, in the dark, with goat-anti-rabbit secondary antibody (LI-COR) diluted 
1:20000. Membranes were again washed three times for 15 minutes with TBST. Gel stains and 
western blots were imaged on LI-COR Odyssey CLx. 
Toxoplasma Actin Expression and Sequence Verification 
Recombinant TgACT1 was amplified by harvesting Sf9 cells infected with recombinant 
baculovirus containing TgACT1 (18) 7 days post infection. Infected Sf9 cells were then 
centrifuged (IEC Centra MP4R) at 800xg for 10 minutes. The pellet was resuspended in 1X 
SDS-PAGE sample buffer, boiled, water bath sonicated for 30 or 60 minutes, and resolved on a 
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10% SDS-PAGE gel followed by western blot.   
Virus was recovered from the Sf9 infection supernatant by centrifugation at 20000xg for 15 
minutes at 4oC in an ultracentrifuge (Optima TLX ultracentrifuge, Beckman TLA 100.3 rotor). 
The pellet was then resuspended in disruption buffer (1M Tris, pH 7.5, 0.1M EDTA, 10% SDS, 
proteinase K) and incubated overnight at 37oC in a water bath. Overnight solution was 
neutralized with neutralization solution and mini prepped (Promega, Madison, WI). gDNA was 
amplified by polymerase chain reaction with Phusion HF DNA Polymerase (New England 
Biolabs, Ipswich, MA) and polyhedrin forward and reverse primers (Table 1) in a Techne Prime 
Thermal Cycler (Staffordshire, UK). Amplified gDNA sequenced with TgACT1 R 157, TgACT1 
R EcorI, TgACT1 F NdeI, TgACT1 F 549. and TgACT1 F 1071 primers (Table 1 & Figure 1b).  
Primer Name Sequence 
Polyhedrin Forward 5’-TTTACTGTTTTCGTAACAGTTTTG-3’ 
Polyhedrin Reverse 5’-CAACAACGCACAGAATCTAG-3’ 
TgACT1 R 157 5’-GCTTCGTCACCGACGTAGC-3’ 
TgACT1 R EcorI 5’-GAATTCTTAGAAGCACTTGCGGTG-3’ 
TgACT1 F NdeI 5’-GCATATGTATGGCGGATGAAGAAGT-3’ 
TgACT1 F 549 5’-ACGCGACCTTACCGAGTAC-3’ 
TgACT1 F 1071 5’-ATCACCAAGGAGGAGTACG-3’ 
Table 1. Amplification and sequencing primers. 
Toxoplasma Actin Expression and Purification 
To express His6-TgACT1 for Histidine affinity purification on a nickel affinity resin, 1*10
9 Sf9 
cells in 200mLs were infected with 3.25mLs 4X recombinant baculovirus containing TgACT1 
for 48 hours. The cells were harvested and pelleted, at ~85% viability post infection, by 
centrifugation (RC5B Centrifuge, Sorvall GSA rotor) at 4000xg for 10 minutes at 4oC. 
The cell pellet was resuspended in G-Actin Buffer (5mM Tris-Cl, pH 7.5, 0.2mM CaCl2, 0.2mM 
ATP) containing 2% Triton X-100 and Protease inhibitor cocktail (Sigma p8340) and sonicated 
(Fisher Scientific, Waltham, MA) on ice at 20% amplitude for 5 seconds pulse on, 10 seconds 
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pulse off, for 4 cycles. Cell lysate was centrifuged at 3000xg (Sorvall SA600 rotor) for 15 
minutes at 4oC. The post spin supernatant was transferred to Ni-NTA column (Invitrogen, 
Carlsbad, CA) and batch adsorbed for one hour at 4oC. The Ni-NTA column was washed with 
Native Wash Buffer (20mM NaPO4, 500mM NaCl, pH 5.5, 0.5% Triton X-100), Native Wash 
Buffer with 0.5M KCl, Native Wash Buffer with 10mM Imidazole and Native Wash Buffer with 
30mM Imidazole. His6-TgACT1 was eluted with G-Actin Buffer containing 100mM Imidazole, 
followed by G-Actin Buffer containing 1M Imidazole. 
His6 Cleavage and TgACT1 Polymerization 
His6-TgACT1 eluted in G-Actin Buffer containing imidazole was dialyzed overnight at 4
oC 
against G-Actin Buffer, and then incubated for 90 minutes with 1U of Thrombin per 10µg His6-
TgACT1 at room temperature. The actin was then transferred to the Ni-NTA column, batch 
adsorbed for one hour at 4oC, and the flow through containing TgACT1 collected.  
F-Actin Buffer salts (100mM KCl, 2mM MgCl2, 2mM ATP) were added to the flow through, 
incubated for 1 hour at room temperature followed by an overnight incubation at 4oC and 
centrifuged (Sorvall T885 rotor) at 300000xg in an ultracentrifuge (Sorvall Discovery 90 
ultracentrifuge) at 4oC. The pellet was resuspended in F-Actin Buffer, dialyzed overnight at 4oC 
in G-Actin Buffer, and centrifuged at 300000xg at 4oC. F-Actin Buffer salts were again added to 
the supernatant and incubated for 1 hour at room temperature followed by an overnight 
incubation at 4oC. The overnight sample was incubated for 1 hour in the dark with TRITC 
phalloidin (Sigma-Aldrich, St. Louis, MO) at an equimolar concentration with the actin, and 
centrifuged at 200000xg at 4oC. Pelleted actin was resuspended in F-Actin Buffer.   
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Protein Quantification 
Protein samples and low molecular weight standards (GE Healthcare, Buckinghamshire, UK) 
were run on Mini-PROTEAN TGX Stain-Free Gels (BIO-RAD, Hercules, CA), and visualized 
by staining with Aqua Stain Protein Gel Stain. Gel staining was imaged on LI-COR Odyssey 
CLx and analyzed with Image Studio Software.  
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